# Mattel Inc: financial statements, quarterly

MAT · Nasdaq · CIK 63276 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mat.md) · [Financials](/companies/mat/financials.md) · [Filings](/companies/mat/filings.md) · [Insiders](/companies/mat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,919](/filings/0001628280-24-044151.md) | [1,621 d](/filings/0001628280-26-010716.md) | [810](/filings/0001628280-25-022312.md) | [1,080](/filings/0001628280-25-036429.md) | [1,844](/filings/0001628280-25-047161.md) | [1,646 d](/filings/0001628280-26-010716.md) | [827](/filings/0001628280-26-029316.md) | [1,019](/filings/0001628280-26-054347.md) | [1,736](/filings/0001628280-25-047161.md) | [1,766 d](/filings/0001628280-26-010716.md) | [862](/filings/0001628280-26-029316.md) | [1,125](/filings/0001628280-26-054347.md) |
| Cost of revenue | $m | [941](/filings/0001628280-24-044151.md) | [830 d](/filings/0001628280-26-010716.md) | [421](/filings/0001628280-25-022312.md) | [549](/filings/0001628280-25-036429.md) | [865](/filings/0001628280-25-047161.md) | [811 d](/filings/0001628280-26-010716.md) | [419](/filings/0001628280-26-029316.md) | [500](/filings/0001628280-26-054347.md) | [868](/filings/0001628280-25-047161.md) | [956 d](/filings/0001628280-26-010716.md) | [475](/filings/0001628280-26-029316.md) | [583](/filings/0001628280-26-054347.md) |
| Gross profit | $m | [978](/filings/0001628280-24-044151.md) | [790 d](/filings/0001628280-26-010716.md) | [389](/filings/0001628280-25-022312.md) | [531](/filings/0001628280-25-036429.md) | [979](/filings/0001628280-25-047161.md) | [835 d](/filings/0001628280-26-010716.md) | [408](/filings/0001628280-26-029316.md) | [519](/filings/0001628280-26-054347.md) | [868](/filings/0001628280-25-047161.md) | [810 d](/filings/0001628280-26-010716.md) | [387](/filings/0001628280-26-029316.md) | [542](/filings/0001628280-26-054347.md) |
| Research and development | $m | [49.8](/filings/0001628280-24-044151.md) | [50.3 d](/filings/0001628280-26-010716.md) | [47.6](/filings/0001628280-25-022312.md) | [47.4](/filings/0001628280-25-036429.md) | [46.8](/filings/0001628280-25-047161.md) | [52.2 d](/filings/0001628280-26-010716.md) | [46.8](/filings/0001628280-26-029316.md) | [49.4](/filings/0001628280-26-054347.md) | [54.5](/filings/0001628280-25-047161.md) | [76.7 d](/filings/0001628280-26-010716.md) | [59.9](/filings/0001628280-26-029316.md) | [70.4](/filings/0001628280-26-054347.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [474](/filings/0001628280-24-044151.md) | [140 d](/filings/0001628280-26-010716.md) | [(35.5)](/filings/0001628280-25-022312.md) | [83.2](/filings/0001628280-25-036429.md) | [488](/filings/0001628280-25-047161.md) | [158 d](/filings/0001628280-26-010716.md) | [(53.0)](/filings/0001628280-26-029316.md) | [78.5](/filings/0001628280-26-054347.md) | [380](/filings/0001628280-25-047161.md) | [141 d](/filings/0001628280-26-010716.md) | [(103)](/filings/0001628280-26-029316.md) | [10.9](/filings/0001628280-26-054347.md) |
| Interest expense | $m | [30.7](/filings/0001628280-23-038124.md) | [31.3 d](/filings/0001628280-24-011371.md) | [30.1](/filings/0001628280-24-019341.md) | [30.0](/filings/0001628280-25-036429.md) | [29.4](/filings/0001628280-25-047161.md) | [29.4 d](/filings/0001628280-26-010716.md) | [29.2](/filings/0001628280-26-029316.md) | [29.4](/filings/0001628280-26-054347.md) | [29.4](/filings/0001628280-25-047161.md) | [30.7 d](/filings/0001628280-26-010716.md) | [31.1](/filings/0001628280-26-029316.md) | [31.8](/filings/0001628280-26-054347.md) |
| Income tax | $m | [309](/filings/0001628280-24-044151.md) | [(27.3) d](/filings/0001628280-26-010716.md) | [(20.8)](/filings/0001628280-25-022312.md) | [9.2](/filings/0001628280-25-036429.md) | [106](/filings/0001628280-25-047161.md) | [10.9 d](/filings/0001628280-26-010716.md) | [(30.6)](/filings/0001628280-26-029316.md) | [16.2](/filings/0001628280-26-054347.md) | [86.9](/filings/0001628280-25-047161.md) | [17.2 d](/filings/0001628280-26-010716.md) | [(32.5)](/filings/0001628280-26-029316.md) | [0.2](/filings/0001628280-26-054347.md) |
| Net income | $m | [146](/filings/0001628280-24-044151.md) | [147 d](/filings/0001628280-26-010716.md) | [(28.3)](/filings/0001628280-25-047161.md) | [56.9](/filings/0001628280-25-047161.md) | [372](/filings/0001628280-25-047161.md) | [141 d](/filings/0001628280-26-010716.md) | [(40.3)](/filings/0001628280-26-054347.md) | [53.4](/filings/0001628280-26-054347.md) | [278](/filings/0001628280-25-047161.md) | [106 d](/filings/0001628280-26-010716.md) | [61.0](/filings/0001628280-26-054347.md) | [(18.2)](/filings/0001628280-26-054347.md) |
| Diluted EPS | $ per share | [0.41](/filings/0001628280-24-044151.md) | not reported | [(0.08)](/filings/0001628280-25-022312.md) | [0.17](/filings/0001628280-25-036429.md) | [1.09](/filings/0001628280-25-047161.md) | not reported | [(0.12)](/filings/0001628280-26-029316.md) | [0.16](/filings/0001628280-26-054347.md) | [0.88](/filings/0001628280-25-047161.md) | not reported | [0.20](/filings/0001628280-26-029316.md) | [(0.06)](/filings/0001628280-26-054347.md) |
| Basic EPS | $ per share | [0.41](/filings/0001628280-24-044151.md) | not reported | [(0.08)](/filings/0001628280-25-022312.md) | [0.17](/filings/0001628280-25-036429.md) | [1.10](/filings/0001628280-25-047161.md) | not reported | [(0.12)](/filings/0001628280-26-029316.md) | [0.16](/filings/0001628280-26-054347.md) | [0.88](/filings/0001628280-25-047161.md) | not reported | [0.21](/filings/0001628280-26-029316.md) | [(0.06)](/filings/0001628280-26-054347.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [456](/filings/0001628280-24-044151.md) | [1,261](/filings/0001628280-25-007887.md) | [1,130](/filings/0001628280-25-022312.md) | [722](/filings/0001628280-25-036429.md) | [724](/filings/0001628280-25-047161.md) | [1,388](/filings/0001628280-26-010716.md) | [1,244](/filings/0001628280-26-029316.md) | [870](/filings/0001628280-26-054347.md) | [692](/filings/0001628280-25-047161.md) | [1,243](/filings/0001628280-26-054347.md) | [866](/filings/0001628280-26-029316.md) | [524](/filings/0001628280-26-054347.md) |
| Current assets | $m | [3,042](/filings/0001628280-24-044151.md) | [3,122](/filings/0001628280-25-007887.md) | [2,735](/filings/0001628280-25-022312.md) | [2,604](/filings/0001628280-25-036429.md) | [3,180](/filings/0001628280-25-047161.md) | [3,127](/filings/0001628280-26-010716.md) | [2,787](/filings/0001628280-26-029316.md) | [2,799](/filings/0001628280-26-054347.md) | [3,156](/filings/0001628280-25-047161.md) | [3,131](/filings/0001628280-26-054347.md) | [2,492](/filings/0001628280-26-029316.md) | [2,453](/filings/0001628280-26-054347.md) |
| Total assets | $m | [6,245](/filings/0001628280-24-044151.md) | [6,436](/filings/0001628280-25-007887.md) | [6,065](/filings/0001628280-25-022312.md) | [5,906](/filings/0001628280-25-036429.md) | [6,514](/filings/0001628280-25-047161.md) | [6,544](/filings/0001628280-26-010716.md) | [6,206](/filings/0001628280-26-029316.md) | [6,249](/filings/0001628280-26-054347.md) | [6,593](/filings/0001628280-25-047161.md) | [6,640](/filings/0001628280-26-054347.md) | [6,330](/filings/0001628280-26-029316.md) | [6,357](/filings/0001628280-26-054347.md) |
| Current liabilities | $m | [1,305](/filings/0001628280-24-044151.md) | [1,342](/filings/0001628280-25-007887.md) | [1,099](/filings/0001628280-25-022312.md) | [1,011](/filings/0001628280-25-036429.md) | [1,299](/filings/0001628280-25-047161.md) | [1,316](/filings/0001628280-26-010716.md) | [1,147](/filings/0001628280-26-029316.md) | [1,726](/filings/0001628280-26-054347.md) | [1,975](/filings/0001628280-25-047161.md) | [1,458](/filings/0001628280-26-054347.md) | [1,211](/filings/0001628280-26-029316.md) | [1,290](/filings/0001628280-26-054347.md) |
| Long-term debt | $m | [2,329](/filings/0001628280-24-044151.md) | [2,330](/filings/0001628280-25-007887.md) | [2,331](/filings/0001628280-25-022312.md) | [2,332](/filings/0001628280-25-036429.md) | [2,333](/filings/0001628280-25-047161.md) | [2,334](/filings/0001628280-26-010716.md) | [2,335](/filings/0001628280-26-029316.md) | [1,738](/filings/0001628280-26-054347.md) | [1,738](/filings/0001628280-25-047161.md) | [2,332](/filings/0001628280-26-054347.md) | [2,333](/filings/0001628280-26-029316.md) | [2,334](/filings/0001628280-26-054347.md) |
| Current portion of debt | $m | [0.0](/filings/0001628280-24-044151.md) | [0.0](/filings/0001628280-25-007887.md) | [0.0](/filings/0001628280-25-022312.md) | [0.0](/filings/0001628280-25-036429.md) | [0.0](/filings/0001628280-25-047161.md) | [0.0](/filings/0001628280-26-010716.md) | [0.0](/filings/0001628280-26-029316.md) | [599](/filings/0001628280-26-054347.md) | [599](/filings/0001628280-25-047161.md) | [0.0](/filings/0001628280-26-054347.md) | [0.0](/filings/0001628280-26-029316.md) | [0.0](/filings/0001628280-26-054347.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001628280-25-007887.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-26-010716.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-26-010716.md) | not reported | not reported |
| Shareholders' equity | $m | [2,035](/filings/0001628280-24-044151.md) | [2,149](/filings/0001628280-26-010716.md) | [2,025](/filings/0001628280-25-047161.md) | [1,973](/filings/0001628280-25-047161.md) | [2,313](/filings/0001628280-25-047161.md) | [2,264](/filings/0001628280-26-054347.md) | [2,130](/filings/0001628280-26-054347.md) | [2,172](/filings/0001628280-26-054347.md) | [2,261](/filings/0001628280-25-047161.md) | [2,233](/filings/0001628280-26-054347.md) | [2,106](/filings/0001628280-26-054347.md) | [1,998](/filings/0001628280-26-054347.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [246 d](/filings/0001628280-24-044151.md) | [949 d](/filings/0001628280-26-010716.md) | [35.5](/filings/0001628280-25-022312.md) | [(253) d](/filings/0001628280-25-036429.md) | [156 d](/filings/0001628280-25-047161.md) | [862 d](/filings/0001628280-26-010716.md) | [24.8](/filings/0001628280-26-029316.md) | [(300) d](/filings/0001628280-26-054347.md) | [72.0 d](/filings/0001628280-25-047161.md) | [797 d](/filings/0001628280-26-010716.md) | [(22.9)](/filings/0001628280-26-029316.md) | [(179) d](/filings/0001628280-26-054347.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [60.0 d](/filings/0001628280-24-044151.md) | [93.2 d](/filings/0001628280-26-010716.md) | [100.0](/filings/0001628280-25-022312.md) | [100.0 d](/filings/0001628280-25-036429.md) | [68.3 d](/filings/0001628280-25-047161.md) | [132 d](/filings/0001628280-26-010716.md) | [160](/filings/0001628280-26-029316.md) | [50.0 d](/filings/0001628280-26-054347.md) | [202 d](/filings/0001628280-25-047161.md) | [188 d](/filings/0001628280-26-010716.md) | [200](/filings/0001628280-26-029316.md) | [100 d](/filings/0001628280-26-054347.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [360](/filings/0001628280-23-038124.md) | [355](/filings/0001628280-24-019341.md) | [357](/filings/0001628280-24-033454.md) | [357](/filings/0001628280-24-044151.md) | [347](/filings/0001628280-25-022312.md) | [344](/filings/0001628280-25-036429.md) | [341](/filings/0001628280-25-047161.md) | [327](/filings/0001628280-26-029316.md) | [326](/filings/0001628280-26-054347.md) | [318](/filings/0001628280-25-047161.md) | [301](/filings/0001628280-26-029316.md) | [289](/filings/0001628280-26-054347.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 285,700,000 at 2026-07-24, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054347.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.